Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Disha Dadke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Liver|March 22, 2002
The detection of HBV antigens and HBx-transcripts in an Indian fibrolamellar carcinoma patient: a case studyDisha Dadke, P Jaganath, Shanta Krishnamurthy, et al.
Biotechniques|March 26, 2002
Protein interaction-targeted drug discovery: evaluating critical issuesErica A Golemis, Kenneth D Tew, Disha Dadke
Cancer Research|December 26, 2003
Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformationDisha Dadke, Benjamin H Fryer, Erica A Golemis, et al.
Oncology and Therapy|July 7, 2024
Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind StudyChristian Schwabe, Chris Wynne, Dayaker Reddy Dyapa, et al.
Molecular Biology of the Cell|January 6, 2006
Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycleDisha Dadke, Michael Jarnik, Elena N Pugacheva, et al.
Molecular Biology of the Cell|February 8, 2008
A novel Cas family member, HEPL, regulates FAK and cell spreadingMahendra K Singh, Disha Dadke, Emmanuelle Nicolas, et al.
Clinical Drug Investigation|June 27, 2024
Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III StudyM V T Krishna Mohan, Arpitkumar Prajapati, Rushabh Kothari, et al.
Journal of Medicinal Chemistry|November 29, 2021
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-<i>N</i>-(2'-methyl-3'-(4-methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-[1,1'-biphenyl]-4-yl)benzamide. Structure-Activity Relationship and Preclinical CharacterizationNilesh Raghunath Khedkar, Nageswara Rao Irlapatti, Disha Dadke, et al.
Molecular & Cellular Proteomics : MCP|October 9, 2019
NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical MethodsMaria Lorna A De Leoz, David L Duewer, Adam Fung, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Liver|March 22, 2002
The detection of HBV antigens and HBx-transcripts in an Indian fibrolamellar carcinoma patient: a case studyDisha Dadke, P Jaganath, Shanta Krishnamurthy, et al.
Biotechniques|March 26, 2002
Protein interaction-targeted drug discovery: evaluating critical issuesErica A Golemis, Kenneth D Tew, Disha Dadke
Cancer Research|December 26, 2003
Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformationDisha Dadke, Benjamin H Fryer, Erica A Golemis, et al.
Oncology and Therapy|July 7, 2024
Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind StudyChristian Schwabe, Chris Wynne, Dayaker Reddy Dyapa, et al.
Molecular Biology of the Cell|January 6, 2006
Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycleDisha Dadke, Michael Jarnik, Elena N Pugacheva, et al.
Molecular Biology of the Cell|February 8, 2008
A novel Cas family member, HEPL, regulates FAK and cell spreadingMahendra K Singh, Disha Dadke, Emmanuelle Nicolas, et al.
Clinical Drug Investigation|June 27, 2024
Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III StudyM V T Krishna Mohan, Arpitkumar Prajapati, Rushabh Kothari, et al.
Journal of Medicinal Chemistry|November 29, 2021
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-<i>N</i>-(2'-methyl-3'-(4-methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-[1,1'-biphenyl]-4-yl)benzamide. Structure-Activity Relationship and Preclinical CharacterizationNilesh Raghunath Khedkar, Nageswara Rao Irlapatti, Disha Dadke, et al.
Molecular & Cellular Proteomics : MCP|October 9, 2019
NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical MethodsMaria Lorna A De Leoz, David L Duewer, Adam Fung, et al.
Pageof 1